HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long term nucleos(t)ide analogue
{{output}}
Background and aims: We examined the role of HBsAg isoforms to predict HBsAg seroclearance or finite treatment among patients with chronic hepatitis B (CHB) infection who stopped long-term nucleoside analogue (NUC). ... ...
